Stock Overview
Arrowhead Pharmaceuticals Inc (ARWR)
NASDAQ · Healthcare · Biotechnology
Arrowhead Pharmaceuticals Inc is a Healthcare company with a market capitalization of $11.11B.
Market Cap
$11.11B
Forward P/E
111.1
Price/Sales
17.9
Price/Book
18.2
EV/EBITDA
27.9
Beta
1.28
EPS (TTM)
$-2.27
Profit Margin
-48.4%
ROE
-42.4%
52W High
$84.55
52W Low
$14.30
5-Year Price History
Latest Annual Financials · FY ending September 30, 2025
Revenue
$829.45M
Gross Profit
$829.45M
Operating Income
$98.35M
Net Income
-$1.63M
Free Cash Flow
$156.89M
Total Debt
$262.17M
Cash & Equivalents
$226.55M
Shareholder Equity
$466.05M
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | May 7, 2026 | $-0.93 | $-1.11 | +16.2% |
| Q1 2025 | February 5, 2026 | $0.22 | $-0.37 | +159.5% |
| Q4 2025 | November 25, 2025 | $-0.11 | $-0.31 | +64.5% |
| Q3 2025 | August 7, 2025 | $-1.26 | $-1.10 | -14.5% |
| Q2 2025 | May 12, 2025 | $2.75 | $-0.46 | +697.8% |
| Q1 2024 | February 10, 2025 | $-1.39 | $-0.72 | -93.1% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Arrowhead Pharmaceuticals Inc's market cap?
As of June 29, 2026, Arrowhead Pharmaceuticals Inc (ARWR) has a market capitalization of $11.11B.
Does Arrowhead Pharmaceuticals Inc pay a dividend?
Arrowhead Pharmaceuticals Inc does not currently pay a dividend.
What sector is ARWR in?
Arrowhead Pharmaceuticals Inc is in the Healthcare sector, specifically the Biotechnology industry.
What was Arrowhead Pharmaceuticals Inc's revenue?
In its latest reported fiscal year (ending September 30, 2025), Arrowhead Pharmaceuticals Inc reported revenue of $829.45M and net income of -$1.63M.
Ask your own questions about ARWR
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.